Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival ...

Men have been urged to contact their GP if they spot three warning signs when visiting the toilet. They could indicate an ...

The NHS has stated that cases of the deadly condition have a higher chance of being 'cured' if detected early.

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...

The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

KILIMANJARO: THE Moshi-based KCMC Zonal Referral Hospital (KCMC ZRH) has achieved a significant medical milestone after ...

New study finds microplastics in 90% of prostate cancer tumors, with double the concentration in cancerous tissue compared to ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.